We are live on ! Find out more
NHI icon

National Health Investors

214 hedge funds and large institutions have $2.24B invested in National Health Investors in 2017 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 24

4% more funds holding

Funds holding: 206214 (+8)

4% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 72

0.58% less ownership

Funds ownership: 72.05%71.47% (-0.58%)

2% less capital invested

Capital invested by funds: $2.28B → $2.24B (-$46.6M)

76% less call options, than puts

Call options by funds: $2.28M | Put options by funds: $9.29M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
214
Holders Change
+8
Holders Change %
+3.88%
% of All Funds
4.85%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
33
Increased
75
Reduced
72
Closed
24
Calls
$2.28M
Puts
$9.29M
Net Calls
-$7.02M
Net Calls Change
+$957K
Name Holding Trade Value Shares
Change
Change in
Stake
VFA
76
Voya Financial Advisors
Connecticut
$1.56M +$1.6M +20,646 New
Nisa Investment Advisors
77
Nisa Investment Advisors
Missouri
$1.5M +$38.8K +500 +3%
QI
78
QS Investors
New York
$1.45M +$193K +2,484 +15%
ACI
79
AMP Capital Investors
Australia
$1.42M +$412K +5,306 +39%
MIM
80
MetLife Investment Management
New Jersey
$1.4M +$1.44M +18,569 New
VOYA Investment Management
81
VOYA Investment Management
Georgia
$1.37M -$50.6K -652 -3%
Schroder Investment Management Group
82
Schroder Investment Management Group
United Kingdom
$1.33M +$132K +1,700 +11%
FLI
83
Family Legacy Inc
South Carolina
$1.31M +$454K +5,852 +51%
AG
84
Aperio Group
California
$1.24M +$84.8K +1,092 +7%
OC
85
Oppenheimer & Co
New York
$1.21M
Stifel Financial
86
Stifel Financial
Missouri
$1.21M -$266K -3,433 -18%
D.E. Shaw & Co
87
D.E. Shaw & Co
New York
$1.2M -$695K -8,960 -36%
JIM
88
Jupiter Investment Management
United Kingdom
$1.13M +$1.16M +14,956 New
SCM
89
Sterling Capital Management
North Carolina
$1.13M +$1.16M +14,923 New
MLICM
90
Metropolitan Life Insurance Company (MetLife)
New York
$1.11M -$1.11M -14,243 -49%
CIP
91
Convergence Investment Partners
Florida
$1.07M +$1.11M +14,260 New
Teacher Retirement System of Texas
92
Teacher Retirement System of Texas
Texas
$1.07M +$837K +10,788 +320%
Janus Henderson Group
93
Janus Henderson Group
United Kingdom
$1.05M -$8.62K -111 -0.8%
DCM
94
Driehaus Capital Management
Illinois
$1.05M -$4.42M -56,925 -80%
MC
95
Menta Capital
California
$1.01M -$101K -1,300 -9%
JG
96
Jefferies Group
New York
$1M -$373K -4,808 -27%
CCM
97
CrestPoint Capital Management
Missouri
$987K +$1.02M +13,100 New
HCM
98
HMS Capital Management
Tennessee
$972K -$2.1K -27 -0.2%
Barclays
99
Barclays
United Kingdom
$941K +$447K +5,758 +86%
Zurich Cantonal Bank
100
Zurich Cantonal Bank
Switzerland
$871K +$51K +657 +6%

NHI Hedge Fund Activity: Q4 2017 in Review

214 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q4 2017, worth a combined $2.24B — down 2% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new NHI positions and 24 closed out — a net gain of 9 holders — while 75 added to existing stakes and 72 trimmed.

The largest buyer was Invesco, adding an estimated $22.1M. The largest seller was JP Morgan Chase, cutting an estimated $30.3M.

  • 214 institutional investors held National Health Investors (NHI) as of Q4 2017, up from 206 in Q3 2017.
  • Funds reported $2.24B of National Health Investors stock for Q4 2017, down 2% quarter-over-quarter.
  • 33 funds opened new National Health Investors positions in Q4 2017 and 24 closed out, a net change of +9 holders.
  • The largest National Health Investors buyer in Q4 2017 was Invesco, an estimated $22.1M added.
  • The largest National Health Investors seller in Q4 2017 was JP Morgan Chase, an estimated $30.3M sold.

Based on aggregated 13F filings for Q4 2017.